Common Equity: The sum of all common equity items.
REGENXBIO Inc. (RGNX) had Common Equity of $71.77M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$108.02M |
|
$22.71M |
|
$1.04M |
|
$106.98M |
|
$78.76M |
|
$29.26M |
|
$-6.55M |
|
$22.71M |
|
$22.71M |
|
$22.71M |
|
$22.71M |
|
$22.71M |
|
$22.71M |
|
$29.26M |
|
$32.58M |
|
52.82M |
|
53.02M |
|
$0.43 |
|
$0.43 |
|
| Balance Sheet Financials | |
$236.16M |
|
$98.45M |
|
$150.46M |
|
$386.62M |
|
$82.62M |
|
-- |
|
$232.23M |
|
$314.85M |
|
|
Common Equity |
$71.77M |
$71.77M |
|
$71.77M |
|
54.16M |
|
| Cash Flow Statement Financials | |
$-138.42M |
|
$136.51M |
|
$3.93M |
|
$36.50M |
|
$38.52M |
|
$2.02M |
|
$17.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
99.04% |
|
27.09% |
|
27.09% |
|
-- |
|
21.02% |
|
21.02% |
|
$-140.42M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
-- |
|
1.01 |
|
88.95 |
|
31.64% |
|
31.64% |
|
5.87% |
|
31.64% |
|
$1.32 |
|
$-2.65 |
|
$-2.61 |
|